Wall Street Signals: Applied BioSciences Receives Distribution from Investment in JUUL

Applied BioSciences Receives Distribution from Investment in JUUL




Applied BioSciences Corp. (APPB), a diversified cannabinoid therapeutics company focused on the medical, bioceutical and pet health industries, announced that has received a capital distribution of approximately $186,000 from its investment in JUUL Labs, Inc. (JUUL).   The company has made strategic investments in select companies they believed to be innovators in the consumer space.  The investment remains on the balance sheet under Equity Investments, but the company has begun a strategic review of options for the remaining equity stake. 
Altria Group Inc. (MO) on December 20, 2018 announced it had invested $12.8bn in vaping company Juul Labs, a 35% stake valuing JUUL at $38 billion.  Howard Willard, Altria’s CEO said in a statement that the move was an effort to “prepare for a future where adult smokers overwhelmingly choose non-combustible products over cigarettes.” 
JUUL has become a success story and one of the fastest growing companies in the US, growing revenue to over $1 billion in a few short years.  Their brand has become synonymous with vaping and the e-cigarette market. 
The global e-cig and vaporizer market is one of the fastest growing consumer markets and has been recently valued at $9.0 billion and expected to grow at a CAGR of 23.6% and reach $49 billion by the end of 2024, according to Research Nestor (www.researchnester.com).
The company continues to make select investments in companies that can help shape the product roadmap and development of new products and potential partnerships.
About Applied BioSciences Corp.
Applied BioSciences Corp. (www.appliedbiocorp.com), is a broadened organization concentrated on various territories of the therapeutic, bioceutical and pet wellbeing industry. As a main organization in the CBD and Pet wellbeing space, the organization is at present dispatching to most of US states just as to 5 International nations. The organization is centered around select venture, shopper brands, and association openings in the recreational, wellbeing and health, nutraceutical, and media businesses.
About Trace Analytics Inc.
Follow Analytics Inc. is a main cannabis science and innovation organization with huge impressions in lab testing, innovative work and permitting. Follow Analytics was begun by a gathering of researchers who represented considerable authority in scientific science, hereditary qualities, and atomic science. The focal point of the group is to guarantee consistence with open wellbeing models and end client security. Follow Analytics is extending all through the United States, and all around. With the objective of helping whatever remains of the world receive "best practices" in cannabis and hemp testing, the organization additionally gives master counseling administrations to administrators and controllers in numerous nations, states, and districts far and wide. For more data, it would be ideal if you visit: http://traceanalytics.com